Shenzhen Kangtai Biological Products
1988
FOUNDED
PUBLIC
STATUS
901-1000
EMPLOYEES
300601
STOCK SYMBOL
$5.48
SHARE PRICE
(As of Thursday Closing)
Description
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Primary Industry
Drug Delivery
Stock Exchange
SHE
Primary Office
- Kefa Road 6, Science & Industry Park
- Nanshan
- Shenzhen
- China
+86 0755 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Kangtai Biological Products’s full profile, request a free trial.
Shenzhen Kangtai Biological Products Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $4.11 - $11.25 | $3.52B | $5.51 | $0.11 | 6.89M | 639M |
Shenzhen Kangtai Biological Products Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 4,032,846 | 3,078,175 | ||
| Revenue | 285,443 | 171,824 | 82,864 | 72,095 |
| EBITDA | 85,968 | 44,032 | 22,004 | 20,515 |
| Net Income | 66,445 | 31,771 | 12,943 | 10,004 |
| Total Assets | 466,593 | 338,615 | 230,551 | 205,463 |
| Total Debt | 74,816 | 45,993 | 52,198 | 40,678 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer